Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Monjuvi | 01/01/2024 | Tafasitamab-Cxix | increased | 972.23 | 100 |
| Mounjaro | 01/01/2024 | Tirzepatide | increased | 972.23 | 100 |
| Mounjaro | 01/01/2024 | Tirzepatide | increased | 972.23 | 100 |
| Moviprep | 01/01/2024 | PEG3350/Sod Sul/NaCl/KCl/Asb/C | increased | 972.23 | 100 |
| Moviprep | 01/01/2024 | PEG3350/Sod Sul/NaCl/KCl/Asb/C | increased | 972.23 | 100 |
| Mresvia | 01/01/2024 | Rsv Vaccine, Pref, Mrna/PF | increased | 972.23 | 100 |
| Mresvia | 01/01/2024 | Rsv Vaccine, Pref, Mrna/PF | increased | 972.23 | 100 |
| Mulpleta | 01/01/2024 | Lusutrombopag | increased | 972.23 | 100 |
| Mulpleta | 01/01/2024 | Lusutrombopag | increased | 972.23 | 100 |
| Mvasi | 01/01/2024 | Bevacizumab-Awwb | increased | 972.23 | 100 |
| Mvasi | 01/01/2024 | Bevacizumab-Awwb | increased | 972.23 | 100 |
| Myalept | 01/01/2024 | Metreleptin | increased | 972.23 | 100 |
| Myalept | 01/01/2024 | Metreleptin | increased | 972.23 | 100 |
| Mycapssa | 01/01/2024 | Octreotide Acetate | increased | 972.23 | 100 |
| Mycapssa | 01/01/2024 | Octreotide Acetate | increased | 972.23 | 100 |
| Myleran | 01/01/2024 | Busulfan | increased | 972.23 | 100 |
| Myleran | 01/01/2024 | Busulfan | increased | 972.23 | 100 |
| Myobloc | 01/01/2024 | Rimabotulinumtoxinb | increased | 972.23 | 100 |
| Myobloc | 01/01/2024 | Rimabotulinumtoxinb | increased | 972.23 | 100 |
| NPlate | 01/01/2024 | Romiplostim | increased | 972.23 | 100 |
| NPlate | 01/01/2024 | Romiplostim | increased | 972.23 | 100 |
| Nabi-Hb | 01/01/2024 | Hepatitis B Immune Globulin | increased | 972.23 | 100 |
| Nabi-Hb | 01/01/2024 | Hepatitis B Immune Globulin | increased | 972.23 | 100 |
| Naglazyme | 01/01/2024 | Galsulfase | increased | 972.23 | 100 |
| Naglazyme | 01/01/2024 | Galsulfase | increased | 972.23 | 100 |
| Nayzilam | 01/01/2024 | Midazolam | increased | 972.23 | 100 |
| Nayzilam | 01/01/2024 | Midazolam | increased | 972.23 | 100 |
| Neffy | 01/01/2024 | Epinephrine | increased | 972.23 | 100 |
| Neffy | 01/01/2024 | Epinephrine | increased | 972.23 | 100 |
| Nemluvio | 01/01/2024 | Nemolizumab-Ilto | increased | 972.23 | 100 |
| Nemluvio | 01/01/2024 | Nemolizumab-Ilto | increased | 972.23 | 100 |
| Nerlynx | 01/01/2024 | Neratinib Maleate | increased | 972.23 | 100 |
| Nerlynx | 01/01/2024 | Neratinib Maleate | increased | 972.23 | 100 |
| Neulasta Onpro | 01/01/2024 | PEGfilgrastim | increased | 972.23 | 100 |
| Neulasta Onpro | 01/01/2024 | PEGfilgrastim | increased | 972.23 | 100 |
| Neulasta | 01/01/2024 | PEGfilgrastim | increased | 972.23 | 100 |
| Neulasta | 01/01/2024 | PEGfilgrastim | increased | 972.23 | 100 |
| Neupogen | 01/01/2024 | Filgrastim | increased | 972.23 | 100 |
| Neupogen | 01/01/2024 | Filgrastim | increased | 972.23 | 100 |
| Nevanac | 01/01/2024 | Nepafenac | increased | 972.23 | 100 |
| Nevanac | 01/01/2024 | Nepafenac | increased | 972.23 | 100 |
| Nexavar | 01/01/2024 | Sorafenib Tosylate | increased | 972.23 | 100 |
| Nexavar | 01/01/2024 | Sorafenib Tosylate | increased | 972.23 | 100 |
| Nexplanon | 01/01/2024 | Etonogestrel | increased | 972.23 | 100 |
| Nexplanon | 01/01/2024 | Etonogestrel | increased | 972.23 | 100 |
| Nexviazyme | 01/01/2024 | Avalglucosidase Alfa-Ngpt | increased | 972.23 | 100 |
| Nexviazyme | 01/01/2024 | Avalglucosidase Alfa-Ngpt | increased | 972.23 | 100 |
| Nilandron | 01/01/2024 | Nilutamide | increased | 972.23 | 100 |
| Nilandron | 01/01/2024 | Nilutamide | increased | 972.23 | 100 |
| Nilutamide | 01/01/2024 | Nilutamide | increased | 972.23 | 100 |